Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Prescription Drug Prices
FDA Under Pressure to Speed Up Generic Approvals
As has been reported, the FDA is under pressure to speed up approval of generic medicines. In response, the FDA released data…
Maryland Sends Bill to Governor on Drug Prices
The Maryland House recently passed a bill – House Bill 631 – with the goal of “prohibiting a manufacturer or wholesale distributor…
Senators Ask GAO to Investigate Potential Orphan Drug Act Abuse
In a March 3, 2017, letter to the United States Government Accountability Office, Senators Orrin Hatch, Chuck Grassley, and Tom…
JAMA Harps on PAOs
JAMA Internal Medicine recently published an article, “Patient Advocacy Organizations, Industry Funding, and Conflicts of…
2016-2025 Projections of National Health Expenditures Data Released
National health expenditure is expected to grow an average of 5.6% annually from 2016 through 2025, according to a report…
Product Price Hikes – When Business and Compliance Collide
2016 was the year of the price increase, as leading industry players experienced significant public outrage over what appeared to…
Avoiding the Patient Assistance Program Spotlight
In efforts to understand the rising cost of some drugs, Patient Assistance programs, particularly independent…
Politico Healthcare Briefing: What’s Next for Drug Costs?
Late last year, Politico Pro’s Health Care Team, along with CVS Health, held a conversation on the future of prescription drug…
U.S. Senators Collins and McCaskill Release Drug Pricing Investigation…
United States Senators Susan Collins (R-ME) and Claire McCaskill (D-MO), the Chairwoman and Ranking Member of the Senate Aging…
Democrat Senators Send Letter to Trump On Drug Pricing
United States Senators Sherrod Brown (D-OH) and Al Franken (D-MN) led the charge to send a letter to President-Elect Donald Trump,…